ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Dogwood Therapeutics Inc

Dogwood Therapeutics Inc (DWTX)

1.91
-0.02
( -1.04% )
Updated: 13:15:14

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
1.91
Bid
1.88
Ask
1.91
Volume
11,447
1.88 Day's Range 1.99
1.62 52 Week Range 5.29
Previous Close
1.93
Open
1.99
Last Trade
40
@
1.8941
Last Trade Time
13:28:18
Average Volume (3m)
46,882
Financial Volume
$ 22,130
VWAP
1.9333

DWTX Latest News

Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

- IMC-2 treatment, dosed as valacyclovir 750 mg + celecoxib 200 mg twice daily, demonstrated clinically meaningful reduction in Long-COVID related fatigue and sleep disturbance as compared to...

Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

- Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) formed in October by combination of Virios Therapeutics, Inc. and Pharmagesic (Holdings) Inc., 100% parent company of Wex Pharmaceuticals, Inc. (the...

Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024

ATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)

Strategic financing by an affiliate of CK Life Sciences Int’l., (Holdings) Inc., results in working capital of approximately $23 million to fund operations and advance Phase 2b Halneuron®...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.52-21.39917695472.432.441.88236662.11893433CS
4-0.4-17.3160173162.312.99991.88292142.51867708CS
12-2.59-57.55555555564.55.151.62468822.93173213CS
26-1.64-46.19718309863.555.291.62764013.46194376CS
52-1.64-46.19718309863.555.291.62764013.46194376CS
156-1.64-46.19718309863.555.291.62764013.46194376CS
260-1.64-46.19718309863.555.291.62764013.46194376CS

DWTX - Frequently Asked Questions (FAQ)

What is the current Dogwood Therapeutics share price?
The current share price of Dogwood Therapeutics is $ 1.91
What is the 1 year trading range for Dogwood Therapeutics share price?
Dogwood Therapeutics has traded in the range of $ 1.62 to $ 5.29 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDMDBaird Medical Investment Holdings Ltd
$ 9.647
(77.99%)
16.45M
CRKNCrown Electrokinetics Corporation
$ 0.1356
(70.14%)
436.66M
BTCTBTC Digital Ltd
$ 7.45
(56.51%)
28.66M
NUKKNukkleus Inc
$ 31.6242
(54.04%)
17.18M
GSITGSI Technology
$ 4.1399
(50.54%)
80.66M
LGCBLinkage Global Inc
$ 0.2894
(-21.78%)
657.58k
PMAXPowell Max Ltd
$ 0.6569
(-20.84%)
3.11M
BLRXBioLineRx Ltd
$ 0.098201
(-19.44%)
23.03M
SHOTWSafety Shot Inc
$ 0.1855
(-17.56%)
3.36k
AENTAlliance Entertainment Holding Corporation
$ 4.95
(-16.67%)
148.88k
CRKNCrown Electrokinetics Corporation
$ 0.1356
(70.14%)
436.66M
GCTKGlucoTrack Inc
$ 0.0955
(29.40%)
428.45M
RIMEAlgorhythm Holdings Inc
$ 0.0415
(-1.89%)
269.81M
TGLTreasure Global Inc
$ 0.272
(26.92%)
252.47M
NVDANVIDIA Corporation
$ 137.9288
(3.26%)
130.79M